John T. Lear

8.7k total citations · 1 hit paper
159 papers, 4.8k citations indexed

About

John T. Lear is a scholar working on Epidemiology, Dermatology and Molecular Biology. According to data from OpenAlex, John T. Lear has authored 159 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Epidemiology, 93 papers in Dermatology and 52 papers in Molecular Biology. Recurrent topics in John T. Lear's work include Nonmelanoma Skin Cancer Studies (89 papers), Hedgehog Signaling Pathway Studies (43 papers) and Cancer and Skin Lesions (42 papers). John T. Lear is often cited by papers focused on Nonmelanoma Skin Cancer Studies (89 papers), Hedgehog Signaling Pathway Studies (43 papers) and Cancer and Skin Lesions (42 papers). John T. Lear collaborates with scholars based in United Kingdom, United States and Germany. John T. Lear's co-authors include Vishal Madan, Rolf‐Markus Szeimies, Anthony A. Fryer, Richard C. Strange, Andrew G. Smith, Peter W. Jones, B. B. Tan, Faisal R. Ali, Sudarshan Ramachandran and Bill Bowers and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

John T. Lear

155 papers receiving 4.7k citations

Hit Papers

align trajectories

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John T. Lear United Kingdom	39	2.6k	2.4k	1.8k	1.4k	472	159	4.8k
David J. Leffell United States	30	1.5k 0.6×	2.1k 0.9×	2.0k 1.1×	1.5k 1.1×	419 0.9×	104	4.6k
Evan R. Farmer United States	37	1.4k 0.5×	1.5k 0.6×	1.0k 0.6×	1.2k 0.9×	487 1.0×	97	4.6k
B.J. Vermeer Netherlands	33	1.9k 0.7×	1.9k 0.8×	724 0.4×	1.2k 0.9×	255 0.5×	106	4.6k
Emmilia Hodak Israel	40	1.6k 0.6×	2.7k 1.1×	480 0.3×	766 0.6×	1.7k 3.6×	219	4.9k
José M. Mascaró Spain	32	680 0.3×	1.1k 0.5×	670 0.4×	629 0.5×	1.8k 3.8×	273	4.3k
M. Bagot France	44	2.2k 0.8×	4.0k 1.7×	840 0.5×	1.7k 1.2×	2.7k 5.8×	365	8.2k
Carlos Ferrándiz Spain	32	1.2k 0.5×	1.9k 0.8×	292 0.2×	900 0.6×	329 0.7×	175	3.5k
Bárður Sigurgeirsson Iceland	38	3.2k 1.2×	3.0k 1.2×	577 0.3×	724 0.5×	843 1.8×	85	7.6k
V. Sibaud France	30	492 0.2×	1.4k 0.6×	542 0.3×	1.7k 1.2×	427 0.9×	158	3.5k
Stefano Piaserico Italy	31	1.2k 0.5×	1.6k 0.6×	351 0.2×	765 0.6×	295 0.6×	158	3.7k

Countries citing papers authored by John T. Lear

Since Specialization

Citations

This map shows the geographic impact of John T. Lear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Lear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Lear more than expected).

Fields of papers citing papers by John T. Lear

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. Lear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Lear. The network helps show where John T. Lear may publish in the future.

Co-authorship network of co-authors of John T. Lear

This figure shows the co-authorship network connecting the top 25 collaborators of John T. Lear. A scholar is included among the top collaborators of John T. Lear based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John T. Lear. John T. Lear is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Pellacani, Giovanni, Tobias Schlesinger, Neal Bhatia, et al.. (2023). Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase‐III trials and the real‐life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022. Journal of the European Academy of Dermatology and Venereology. 38(S1). 3–15. 5 indexed citations

2.

Lear, John T., et al.. (2023). Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinoma. Expert Review of Clinical Pharmacology. 16(12). 1211–1220. 3 indexed citations

3.

Smith, Isabelle L, Sarah Brown, Catherine Fernandez, et al.. (2022). Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial. BMJ Open. 12(2). e060029–e060029. 2 indexed citations

4.

Budden, Timothy, Caroline Gaudy‐Marqueste, Sarah Craig, et al.. (2021). Female Immunity Protects from Cutaneous Squamous Cell Carcinoma. Clinical Cancer Research. 27(11). 3215–3223. 11 indexed citations

5.

Dummer, Reinhard, Paolo A. Ascierto, Nicole Basset‐Séguin, et al.. (2020). Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion. Journal of the European Academy of Dermatology and Venereology. 34(9). 1944–1956. 109 indexed citations

6.

Lear, John T., Michael R. Migden, Karl D. Lewis, et al.. (2017). Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study. Journal of the European Academy of Dermatology and Venereology. 32(3). 372–381. 137 indexed citations

7.

Lear, John T., Ralf Gutzmer, Michael R. Migden, et al.. (2016). Investigator-assessed efficacy and safety of sonidegib in patients with locally advanced basal cell carcinoma and metastatic basal cell carcinoma: results of the BOLT 30-month analysis. Melanoma Research. 1 indexed citations

8.

Ulrich, Claas, Carmen Sălăvăstru, Tove Agner, et al.. (2016). The European Status Quo in legal recognition and patient‐care services of occupational skin cancer. Journal of the European Academy of Dermatology and Venereology. 30(S3). 46–51. 36 indexed citations

9.

Ali, Faisal R., et al.. (2016). Non-melanoma skin cancer. Clinical Medicine. 16(1). 62–65. 84 indexed citations

10.

Ali, Faisal R. & John T. Lear. (2012). Melanoma in Organ Transplant Recipients: Incidence, Outcomes and Management Considerations. Journal of Skin Cancer. 2012. 1–5. 8 indexed citations

11.

Ali, Faisal R., et al.. (2012). Use of Photodynamic Therapy for Treatment of Actinic Keratoses in Organ Transplant Recipients. BioMed Research International. 2013. 1–7. 18 indexed citations

12.

Lear, John T., Christina Sze Man Wong, C.E.M. Griffiths, et al.. (2005). Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors. Journal of the American Academy of Dermatology. 52(3). 468–473. 60 indexed citations

13.

Strange, Richard C., Sudarshan Ramachandran, Anthony A. Fryer, et al.. (2004). Susceptibility to Basal Cell Carcinoma: Associations with PTCH Polymorphisms. Annals of Human Genetics. 68(6). 536–545. 20 indexed citations

14.

Ramachandran, Sudarshan, Anthony A. Fryer, Andrew G. Smith, et al.. (2001). Cutaneous basal cell carcinomas. Cancer. 92(2). 354–358. 50 indexed citations

15.

Ramachandran, Sudarshan, John T. Lear, Helen Ramsay, et al.. (1999). Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype.. PubMed. 8(1). 61–7. 54 indexed citations

16.

Ramachandran, Sudarshan, John T. Lear, Andrew G. Smith, et al.. (1999). The melanocyte stimulating hormone receptor polymorphism: association of the V92M and A294H alleles with basal cell carcinoma. Clinica Chimica Acta. 282(1-2). 125–134. 16 indexed citations

17.

Lear, John T., et al.. (1998). A COMPARISON OF RISK FACTORS FOR MALIGNANT MELANOMA, SQUAMOUS CELL CARCINOMA AND BASAL CELL CARCINOMA IN THE UK. International Journal of Clinical Practice. 52(3). 145–149. 28 indexed citations

18.

Yengi, Lilian, Janice Gilford, Julie Alldersea, et al.. (1996). Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma.. PubMed. 56(9). 1974–7. 104 indexed citations

19.

Heagerty, Adrian, Andrew G. Smith, John English, et al.. (1996). Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender. British Journal of Cancer. 73(1). 44–48. 39 indexed citations

20.

Lear, John T., et al.. (1994). Myocardial Infarction and Thrombolysis: A Comparison of the Indian and European Populations on a Coronary Care Unit. Journal of the Royal College of Physicians of London. 28(2). 143–147. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact